Daniel Blum
Amministratore Delegato presso BIOHEMP INTERNATIONAL, INC.
Posizioni attive di Daniel Blum
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOHEMP INTERNATIONAL, INC. | Direttore/Membro del Consiglio | 15/05/2019 | - |
| Amministratore Delegato | 15/05/2019 | - | |
| Presidente | 15/05/2019 | - | |
| Segretario Aziendale | 15/05/2019 | - | |
| Treasurer | 15/05/2019 | - |
Storia della carriera di Daniel Blum
Formazione di Daniel Blum
| Union College (Kentucky) | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| President | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Biohemp International, Inc.
 Biohemp International, Inc. Pharmaceuticals: MajorHealth Technology Biohemp International, Inc. operates as a pharmaceutical company, which provides insomnia remedy. The firm has developed Zleepax, which is a sleep aid with beta blockers as the major active agent. The company was founded by Briger Jan Olsen on August 11, 2012 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Daniel Blum
- Esperienza
